Siegfried (SGFEF) Stock Price, News & Analysis

Company Overview

Siegfried Holding AG is a Swiss pharmaceutical services company that develops and manufactures active pharmaceutical ingredients (APIs) and finished dosage forms for pharmaceutical and healthcare companies. Its offerings include chemical and biological drug substances, oral solid doses, sterile and nonsterile liquid formulations, and other specialized pharmaceutical products.

The company provides services across the pharmaceutical value chain, including process development, analytical development, scale-up, commercial manufacturing, packaging and logistics. Siegfried supports both proprietary pharmaceutical products and customer projects, serving companies that outsource the development and production of medicines.

Founded in 1873 by Samuel Siegfried and headquartered in Zofingen, Switzerland, Siegfried has expanded from its Swiss origins into an international contract development and manufacturing organization. Its operations and customer base span key pharmaceutical markets in Europe, North America and Asia, with manufacturing and development activities conducted through sites in multiple countries.

Key Stats

• Today's Range: $88.12 to $88.12
• 50-Day Range: $71.15 to $90.70
• 52-Week Range: $65.15 to $90.70
• Volume: N/A
• Average Volume: 203 shs
• Market Capitalization: N/A
• P/E Ratio: 6.38
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

Siegfried Stock Analysis - MarketRank™

Siegfried scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

Siegfried has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Siegfried has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Siegfried is 6.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.92.

Price to Earnings Ratio vs. Sector

The P/E ratio of Siegfried is 6.38, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.42.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Siegfried has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Siegfried has recently increased by 10.37%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Siegfried does not currently pay a dividend.

Dividend Growth

Siegfried does not have a long track record of dividend growth.

News and Social Media

• Score: N/A
• News Sentiment: N/A

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Siegfried insiders have not sold or bought any company stock.

Percentage Held by Institutions

19.09% of the stock of Siegfried is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:SGFEF
• CIK: N/A
• Web: www.siegfried.ch
• Phone: 41 62 746 1111
• Fax: N/A
• Employees: 3,819
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 6.38
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A